The uk has become the primary country to authorise the Pfizer-BioNTech COVID-19 vaccine to be used . Britain on December 2 said that the COVID-19 vaccine are going to be unrolled to be used from next week. The emergency authorization clears the way for the deployment of a vaccine that’s expected to play a big role within the global effort to halt the coronavirus.
The vaccine are going to be made available across the united kingdom from next week,” it added.
“The Government has today accepted the advice from the independent Medicines and Healthcare products regulatory authority (MHRA) to approve Pfizer-BioNTech’s COVID-19 vaccine to be used ,” the govt said.
While the united kingdom has ordered enough Pfizer vaccine for 20 million people, it’s not clear what percentage will arrive by year’s end. Adding to the distribution challenges, the Pfizer vaccine must be stored at ultra-cold temperatures. Two doses three weeks apart are required for cover .
The U.K. government says frontline health care workers and home residents are going to be first in line to urge vaccinated, followed by older adults.
Pfizer said Britain’s emergency use authorization marks a historic moment within the fight against COVID-19. “This authorization may be a goal we’ve been working toward since we first declared that science will win, and that we applaud the MHRA for his or her ability to conduct a careful assessment and take timely action to assist protect the people of the united kingdom ,” said Pfizer CEO Albert Bourla.
Health Secretary Matt Hancock said the programme would begin early next week. “Hospitals are already able to receive the COVID-19 vaccine. it’s excellent news,” Hancock said.
Pfizer Inc on November 18 said its COVID-19 vaccine with partner BioNTech SE was 95 percent effective within the end supported clinical trials data. This 95 percent effectiveness rate brings the experimental candidate on par with the likes of shingles and measles vaccines.
The companies also reported no serious side effects, although vaccine recipients may experience temporary pain and flu-like reactions immediately after injections.